MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
SCYNEXIS ROE Ratio 2011-2026 | SCYX
Annual ROE Ratio SCYNEXIS
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91.88 | -1942.75 | -79.66 | -242.49 | -416.52 | -39.93 | -117.05 | -86.13 | -77.77 | -12.66 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 91.88 | -1942.75 | -292.31 |
Quarterly ROE Ratio SCYNEXIS
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -54.53 | -35.75 | -44.2 | -28.18 | -30.09 | -27.2 | 128.09 | 242.69 | 70.78 | -99.22 | -259.92 | -215.26 | -216.86 | -46.56 | -12.09 | -14.52 | -10.52 | -4.92 | -38.09 | -54.81 | -116.39 | -181.97 | -219.1 | -304.4 | -303.27 | -240.57 | -209.85 | -46.14 | -85.38 | -125.74 | -110.91 | -81.59 | -91.5 | -84.51 | -88.24 | -86.13 | -96.22 | -83.89 | -83.18 | -77.77 | -69.15 | -60.62 | -31.3 | -3.47 | 0.2 | 15.24 | 11.06 | 8.08 | 8.08 | 4.41 | 1.91 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 242.69 | -304.4 | -70.26 |
ROE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
-162.53 | - | 7.5 % | $ 6.35 M | USA |
 |
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | USA |
 |
DURECT Corporation
DRRX
|
-186.86 | - | - | $ 50.1 M | USA |
 |
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M |  Irlanda |
 |
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | USA |
 |
Canopy Growth Corporation
CGC
|
-122.76 | $ 1.1 | 2.84 % | $ 118 M |  Canada |
 |
Evoke Pharma
EVOK
|
302.08 | - | - | $ 36.6 M | USA |
 |
Alimera Sciences
ALIM
|
-43.6 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
-4.28 | $ 2.64 | 1.35 % | $ 1.38 B | Canada |
 |
Evolus
EOLS
|
223.5 | $ 5.68 | 37.53 % | $ 366 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
2273.74 | - | - | $ 33.6 M | USA |
 |
China Pharma Holdings
CPHI
|
-61.13 | $ 0.59 | 6.08 % | $ 10.3 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.33 | $ 3.81 | -16.81 % | $ 53.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-50.54 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-98.17 | - | 2.45 % | $ 38.1 M | Canada |
 |
Harrow Health
HROW
|
-9.8 | $ 40.02 | 3.65 % | $ 1.47 B | USA |
 |
Neoleukin Therapeutics
NLTX
|
7.34 | - | - | $ 193 M | Canada |
 |
Aurora Cannabis
ACB
|
-154.42 | $ 3.65 | 4.89 % | $ 86.3 M | Canada |
 |
Athenex
ATNX
|
1589.72 | - | -23.39 % | $ 1.76 M | USA |
 |
Emergent BioSolutions
EBS
|
-117.13 | $ 8.95 | 0.39 % | $ 458 M | USA |
 |
ProPhase Labs
PRPH
|
29.02 | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
-240.53 | $ 12.19 | 2.48 % | $ 866 M | USA |
 |
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
57.93 | $ 5.67 | -0.87 % | $ 2.07 B | Canada |
 |
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.33 | $ 2.87 | 0.01 % | $ 378 M | USA |
 |
OrganiGram Holdings
OGI
|
-45.46 | $ 1.4 | 2.19 % | $ 402 M | Canada |
 |
Rockwell Medical
RMTI
|
-39.64 | $ 0.91 | 1.03 % | $ 21.2 M | USA |
 |
Perrigo Company plc
PRGO
|
-48.56 | $ 11.71 | 2.81 % | $ 1.62 B | USA |
 |
Sundial Growers
SNDL
|
-88.87 | $ 1.55 | 1.21 % | $ 3.37 M | Canada |
 |
TherapeuticsMD
TXMD
|
-35.09 | $ 2.25 | 1.35 % | $ 23.5 M | USA |
 |
Veru
VERU
|
-116.97 | $ 2.53 | 0.4 % | $ 341 M | USA |
 |
Viatris
VTRS
|
0.27 | $ 14.74 | -1.04 % | $ 17.7 B | USA |
 |
Pacira BioSciences
PCRX
|
-12.79 | $ 22.92 | 3.69 % | $ 1.06 B | USA |
 |
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
40.97 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | USA |
 |
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
-115.74 | $ 4.79 | 2.57 % | $ 144 M | USA |
 |
cbdMD
YCBD
|
-7.78 | $ 0.75 | -2.76 % | $ 3.23 M | USA |
 |
Solid Biosciences
SLDB
|
-90.86 | $ 6.14 | 3.02 % | $ 251 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-78.37 | $ 2.74 | -0.36 % | $ 3.4 M | USA |
 |
Tricida
TCDA
|
-80993.58 | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
-43.81 | $ 7.33 | -0.48 % | $ 4.53 B | Canada |
 |
Zynerba Pharmaceuticals
ZYNE
|
-75.79 | - | - | $ 55.5 M | USA |